Intas enters into exclusive licence agreement with Syna to commercialise LB-0702 in gobal markets EP News Bureau Nov 7, 2022 Syna will develop and manufacture LB-0702 and supply the product to Intas and its worldwide affiliates
Intas launches Romiplostim in India EP News Bureau Jul 11, 2019 With this, the drug firm makes therapy for chronic immune thrombocytopenia (ITP) more accessible to patients
